argus

Morepen Laboratories Ltd.

NSE: MOREPENLABINE083A010266,186 Cr

Timeline

Time (IST)TypeMEventSrc
02 Sept, 01:50 pmprocedural0Morepen Laboratories Limited has informed the Exchange regarding the dispatch of the Letter to Members comprising the Weblink of the Annual Report for the financial year 2025-26.nse
02 Sept, 01:14 pmprocedural0Filing of the Annual Report for FY 2025-26 and notice of the 41st AGM.bse
26 Aug, 11:04 amNewspaper publication-information relating to 41st Annual General Meeting, Dividend and Record Datense
06 Aug, 05:10 pmMorepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Acquisitionbse
06 Aug, 05:02 pmMorepen Laboratories Limited has informed the Exchange about allotment of equity shares by Morepen RX Limited, wholly owned subsidiary, to the companynse
05 Aug, 12:26 pmMorepen Laboratories Limited has informed the Exchange about Newspaper Publication - Financial Results for the quarter ended June 30, 2026nse
04 Aug, 03:46 pmMorepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Monitoring Agency Reportbse
04 Aug, 03:42 pmMonitoring agency report for the quarter ended June 30, 2026nse
04 Aug, 02:36 pmMorepen Laboratories Limited has informed the Exchange about Intimation of 41st Annual General Meeting scheduled to be held on September 26, 2026nse
04 Aug, 02:23 pmMorepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Change in Managementbse
04 Aug, 02:20 pmMorepen Laboratories Limited has informed the Exchange regarding re- appointment of Mr. Sushil Suri as Chairman & Managing Director of the company w.e.f. October 20, 2026.nse
04 Aug, 02:17 pmMorepen Laboratories Ltd - 500288 - Intimation Of Record Date For Payment Of Final Dividend I.E. September 19, 2026bse
04 Aug, 02:12 pmMorepen Laboratories Limited has informed the Exchange that Record date for the purpose of Final Dividend is 19-Sep-2026.nse
04 Aug, 02:06 pmMorepen Laboratories Limited has informed the Exchange regarding a press release dated August 04, 2026, titled "Morepen clocks highest-ever quarterly revenue and earnings in Q1 FY27; EBITDA grows by 207% and PAT by 394%; CDMO enters full scale commercialization".nse
04 Aug, 02:03 pmMorepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
04 Aug, 02:01 pmMorepen Laboratories Limited has informed the Exchange about Investor Presentationnse
04 Aug, 01:58 pmMorepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
04 Aug, 01:50 pmMorepen Laboratories Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.nse
04 Aug, 01:46 pmMorepen Laboratories Ltd - 500288 - Board Meeting Outcome for For Q1 FY 27 Financial Resultsbse
04 Aug, 01:43 pmMorepen Laboratories Ltd - 500288 - Q1 FY 27 Financial Resultsbse
28 Jul, 05:06 pmMorepen Laboratories Ltd - 500288 - Board Meeting Intimation for Q-1 FY27 Resultsbse
23 Jul, 06:48 pmMOREPENLAB: Morepen Laboratories Limited has informed the Exchange about Name Change Of Wholly Owned Subsidiary Company from "Morepen Labs - FZCO" to "Morepen Labs FZE"nse
06 Jul, 07:33 pmMorepen Laboratories Limited has informed the Exchange about Resignation of Director/KMP/SMPnse
06 Jul, 07:25 pmMorepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Change in Managementbse
06 Jul, 07:24 pmMorepen Laboratories Limited has informed the Exchange regarding resignation of Mr. Bhola Prasad as General Manager Process Engineering & Technology Transfer, a functional head, being a Senior Management Personnel of the company w.e.f. July 06, 2026.nse
01 Jul, 08:46 amMorepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
01 Jul, 08:44 amMorepen Laboratories Limited has informed the Exchange regarding a press release dated July 01, 2026, titled Morepen starts commercial supplies under its ₹ 825 Crore CDMO mandate.nse
30 Jun, 06:38 pmMorepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Change in Managementbse
30 Jun, 06:37 pmMorepen Laboratories Limited has informed the Exchange about elevation and change in designation of Mr. Sanjay Surinse
10 Jun, 01:31 pmprocedural0Morepen Laboratories Ltd submitted its reply to the exchange clarification on price movement (no business/financial figures disclosed).bse
10 Jun, 12:57 pmprocedural0BSE sought clarification from Morepen Laboratories Ltd on June 10, 2026 regarding movement in volume; the company’s reply is awaited.bse
09 Jun, 08:02 pmprocedural0NSE noted a significant increase in volume in Morepen Laboratories and sought clarification; the company submitted its response.nse
09 Jun, 06:19 pmprocedural0NSE noted a significant spurt in Morepen Laboratories Limited’s trading volume and wrote to the company; company’s response is awaited.nse
05 Jun, 05:46 pmDilesh Roadlines Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
27 May, 08:28 amMorepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
27 May, 08:25 amMorepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
27 May, 08:22 amMorepen Laboratories Limited has informed the Exchange regarding a press release dated May 27, 2026, titled "Morepen Labs Q4 Net Profit Rises 69%; CDMO Program Moves into Commercial Execution; Board Proposes a Dividend of 10% to the shareholders for FY26.".nse
27 May, 08:22 amMorepen Laboratories Limited has informed the Exchange about Investor Presentationnse
26 May, 06:04 pmMorepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Change in Managementbse
26 May, 05:56 pmMorepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreementsbse
26 May, 05:53 pmMorepen Laboratories Ltd - 500288 - Corporate Action-Board approves Dividendbse
26 May, 05:47 pmMorepen Laboratories Ltd - 500288 - Please Find Attached Quarter And Financial Year Ended March 31, 2026 Financial Resultsbse
26 May, 05:40 pmMorepen Laboratories Limited has informed the Exchange regarding Re-appointment of Cost Auditors of the companynse
26 May, 05:40 pmMorepen Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 26, 2026, recommended Final Dividend of Rs. 0.20 per equity share.nse
26 May, 05:40 pmMorepen Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
26 May, 05:40 pmMorepen Laboratories Limited has informed the Exchange about Amendment to BTAnse
26 May, 05:36 pmMorepen Laboratories Ltd - 500288 - Board Meeting Outcome for Board Meeting Outcome For Q4 And FY26 Resultsbse
21 May, 07:38 pmMorepen Laboratories Ltd - 500288 - Update on board meetingbse
20 May, 07:13 pmMorepen Laboratories Limited has informed the Exchange about General Updatesnse
20 May, 07:10 pmMorepen Laboratories Ltd - 500288 - Announcement under Regulation 30 (LODR)-Restructuringbse